Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
- Citation:
- J Thorac Oncol vol 10 (7) 1099-106
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, U10 CA031946, U10 CA033601, U10 CA180821, U10 CA066636, U10 CA180882, CA25224, U10 CA023318, P01 CA142538, U10 CA180794, U10 CA180867, U10 CA025224, U10 CA180888, U10 CA180819, CA31946
- Corr. Author:
- Authors:
- Nathan R. Foster Lindsay A. Renfro Steven E. Schild Mary W. Redman Xiaofei F. Wang Suzanne E. Dahlberg Keyue Ding Penelope A. Bradbury Suresh S. Ramalingam David R. Gandara Taro Shibata Nagahiro Saijo Everett E. Vokes Alex A. Adjei Sumithra J. Mandrekar
- Networks:
- LAPS-IL057, LAPS-MN026, LAPS-NC010
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-30103, NCCTG-N0424, NCCTG-932053
- Phases:
- 2
- Keywords:
- Article